P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

Authors :: Nozzoli, C.
Pucillo, M.
Martino, M.
Giaccone, L.
Rambaldi, A.
Benedetti, E.
Russo, D.
Mordini, N.
Bernasconi, P.
Mangiacavalli, S.
Pioltelli, P.
Carluccio, P.
Galieni, P.
Ladetto, M.
Sica, S.
Isola, M.
De Martino, M.
Oldani, E.
Degrandi, E.
Biasco, A.
Source :: HemaSphere; May2023 Supplement S2, Vol. 7, p38-38, 1p
Publication Year :: 2023

Full Text Access

Tools